Mapping vaccination coverage to explore the effects of delivery mechanisms and inform vaccination strategies.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
09 04 2019
Historique:
received: 13 07 2018
accepted: 21 03 2019
entrez: 11 4 2019
pubmed: 11 4 2019
medline: 9 5 2019
Statut: epublish

Résumé

The success of vaccination programs depends largely on the mechanisms used in vaccine delivery. National immunization programs offer childhood vaccines through fixed and outreach services within the health system and often, additional supplementary immunization activities (SIAs) are undertaken to fill gaps and boost coverage. Here, we map predicted coverage at 1 × 1 km spatial resolution in five low- and middle-income countries to identify areas that are under-vaccinated via each delivery method using Demographic and Health Surveys data. We compare estimates of the coverage of the third dose of diphtheria-tetanus-pertussis-containing vaccine (DTP3), which is typically delivered through routine immunization (RI), with those of measles-containing vaccine (MCV) for which SIAs are also undertaken. We find that SIAs have boosted MCV coverage in some places, but not in others, particularly where RI had been deficient, as depicted by DTP coverage. The modelling approaches outlined here can help to guide geographical prioritization and strategy design.

Identifiants

pubmed: 30967543
doi: 10.1038/s41467-019-09611-1
pii: 10.1038/s41467-019-09611-1
pmc: PMC6456602
doi:

Substances chimiques

Diphtheria-Tetanus-Pertussis Vaccine 0
Measles Vaccine 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1633

Subventions

Organisme : Wellcome Trust
ID : 211208/Z/18/Z
Pays : United Kingdom
Organisme : NICHD NIH HHS
ID : P2C HD047879
Pays : United States

Références

Pan Afr Med J. 2017 Jun 21;27(Suppl 3):7
pubmed: 29296142
Sci Data. 2017 Jan 31;4:170004
pubmed: 28140397
PLoS Med. 2013;10(5):e1001404
pubmed: 23667334
Vaccine. 2016 Dec 20;34(52):6691-6699
pubmed: 27887796
Vaccine. 2016 Jul 29;34(35):4103-4109
pubmed: 27349841
J Infect Dis. 2011 Jul;204 Suppl 1:S343-52
pubmed: 21666183
BMC Public Health. 2008 May 16;8:161
pubmed: 18485194
BMC Med Res Methodol. 2017 Apr 20;17(1):67
pubmed: 28427337
Vaccine. 2016 Dec 20;34(52):6707-6714
pubmed: 27773475
MMWR Morb Mortal Wkly Rep. 2017 Nov 17;66(45):1252-1255
pubmed: 29145357
J R Soc Interface. 2017 Apr;14(129):
pubmed: 28381641
Int J Health Geogr. 2007 Jun 07;6:23
pubmed: 17555557
Vaccine. 2011 Oct 26;29(46):8215-21
pubmed: 21893149
Bull World Health Organ. 1999;77(9):722-30
pubmed: 10534895
Int Health. 2014 Sep;6(3):213-24
pubmed: 24844557
PLoS One. 2017 Sep 27;12(9):e0185533
pubmed: 28953970
Vaccine. 2019 Jan 7;37(2):219-222
pubmed: 28760612
J R Soc Interface. 2013 May 08;10(84):20130246
pubmed: 23658117
BMC Public Health. 2012 Jun 22;12:476
pubmed: 22726457
Vaccine. 2017 Mar 13;35(11):1488-1493
pubmed: 28216186
Vaccine. 2017 May 19;35(22):2871-2881
pubmed: 28438406
Vaccine. 2018 Jan 2;36(1):170-178
pubmed: 29174680
Br Med Bull. 2015 Mar;113(1):5-14
pubmed: 25649959
World Health Stat Q. 1988;41(2):59-63
pubmed: 3176515
Lancet. 2017 Nov 11;390(10108):2171-2182
pubmed: 28958464
Epidemiol Infect. 2015 May;143(7):1457-66
pubmed: 25119237
J Stat Softw. 2007 Apr;19(4):1-24
pubmed: 21494410
Nature. 2008 Feb 7;451(7179):679-84
pubmed: 18256664
Wellcome Open Res. 2017 Feb 15;2:12
pubmed: 28459105
J Infect Dis. 2014 Nov 1;210 Suppl 1:S531-9
pubmed: 25316877
Vaccine. 2017 Feb 15;35(7):1087-1093
pubmed: 28081971
Bull World Health Organ. 2012 Jul 1;90(7):495-503
pubmed: 22807595
Vaccine. 2018 Mar 14;36(12):1583-1591
pubmed: 29454519
Nat Commun. 2017 May 25;8:15585
pubmed: 28541287
BMC Public Health. 2016 Aug 30;16:905
pubmed: 27578303
BMC Public Health. 2014 Aug 22;14:865
pubmed: 25146502
Int Health. 2012 Dec;4(4):229-38
pubmed: 24029668
BMC Public Health. 2008 Nov 05;8:381
pubmed: 18986544

Auteurs

C Edson Utazi (CE)

WorldPop, School of Geography and Environmental Science, University of Southampton, Southampton, SO17 1BJ, UK. c.e.utazi@soton.ac.uk.
Southampton Statistical Sciences Research Institute, University of Southampton, Southampton, SO17 1BJ, UK. c.e.utazi@soton.ac.uk.

Julia Thorley (J)

WorldPop, School of Geography and Environmental Science, University of Southampton, Southampton, SO17 1BJ, UK.

Victor A Alegana (VA)

WorldPop, School of Geography and Environmental Science, University of Southampton, Southampton, SO17 1BJ, UK.
Flowminder Foundation, Stockholm SE, 11355, Sweden.

Matthew J Ferrari (MJ)

Center for Infectious Disease Dynamics, The Pennsylvania State University, State College, PA, 16802, USA.

Saki Takahashi (S)

Department of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ, 08544, USA.

C Jessica E Metcalf (CJE)

Department of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ, 08544, USA.

Justin Lessler (J)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 21205, USA.

Felicity T Cutts (FT)

Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, WC1E 7HT, UK.

Andrew J Tatem (AJ)

WorldPop, School of Geography and Environmental Science, University of Southampton, Southampton, SO17 1BJ, UK.
Flowminder Foundation, Stockholm SE, 11355, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH